Evaluating the Cardiovascular Event Profile After Administration of Tixagevimab and Cilgavimab (Evusheld) in Lung Transplant Recipients

被引:0
|
作者
Bulger, J. L. [1 ]
Ching, K. [2 ]
Joyce, C. [3 ]
Warrior, K. [1 ]
机构
[1] Loyola Univ Med Ctr, Pulm Crit Care, Maywood, IL USA
[2] Loyola Univ Med Ctr, Internal Med, Maywood, IL USA
[3] Loyola Univ Med Ctr, Ctr Translat Res & Educ, Maywood, IL USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6578
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk
    Alejo, Jennifer L.
    Kim, Jake D.
    Chiang, Teresa P. Y.
    Avery, Robin K.
    Karaba, Andrew H.
    Jefferis, Alexa
    Warren, Daniel S.
    Massie, Allan B.
    Tobian, Aaron A. R.
    Segev, Dorry L.
    Werbel, William A.
    CLINICAL TRANSPLANTATION, 2023, 37 (04)
  • [32] SARS-CoV-2 Vaccination Rates and Uptake of Tixagevimab-Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients
    Reis, C.
    Madigan, T.
    Ristagno, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S390 - S390
  • [33] SARS-CoV-2 Vaccination Rates and Uptake of Tixagevimab-Cilgavimab Among a Cohort of Pediatric Solid Organ Transplant Recipients
    Reis, Christopher A.
    Ristagno, Elizabeth H.
    Madigan, Theresa
    CLINICAL TRANSPLANTATION, 2024, 38 (07)
  • [34] Tixagevimab/Cilgavimab as SARS-CoV-2 Pre-Exposure Prophylaxis in Lung Transplant Recipients during the Omicron Wave: A Real-World Monocentric Experience
    Cona, Andrea
    Tavelli, Alessandro
    Agrenzano, Stefano
    Hafeez, Neha
    Scianna, Giovanni
    Maria, Angelo
    Marino, Francesco
    Cruz, Elizabeth De La
    Giorgio, Maria Di
    Osorio, Eglys
    Cucinella, Giuseppe
    Luca, Angelo
    Provenzani, Alessio
    Vitulo, Patrizio
    Bertani, Alessandro
    Grossi, Paolo Antonio
    Mularoni, Alessandra
    MICROORGANISMS, 2024, 12 (07)
  • [35] Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients
    Angelico, Roberta
    Romano, Francesca
    Coppola, Luigi
    Materazzo, Marco
    Pedini, Domiziana
    Santicchia, Maria Sara
    Cacciola, Roberto
    Toti, Luca
    Sarmati, Loredana
    Tisone, Giuseppe
    MEDICINA-LITHUANIA, 2023, 59 (12):
  • [36] Assessing the post hoc effectiveness of tixagevimab-cilgavimab for prevention of SARS-CoV-2 infections in solid organ transplant recipients
    Jordan, Stanley C.
    Joung, Sandy Y.
    Wang, Minhao
    Tran, Teresa Anh
    Bravo, Michelle
    Masoom, Hibah
    Chang, Christine
    Mendez, Marilyn
    Patel, Jignesh
    Sun, Nancy
    Kittleson, Michelle
    Frias, Edwin
    Prostko, John C.
    Ebinger, Joseph E.
    Cheng, Susan
    Sobhani, Kimia
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [37] Risk factors for breakthrough COVID-19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre-exposure prophylaxis
    Abraham, Dana L.
    Lichvar, Alicia B.
    Brubaker, Aleah L.
    Haste, Nina
    Chen, Victor
    Abeles, Shira
    Aslam, Saima
    Yam, Nancy
    Horton, Lucy
    Chen, Benjamin
    Binkin, Nancy
    Law, Nancy
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [38] Risk Factors for Breakthrough Covid-19 Infections in Solid Organ Transplant Recipients Receiving Tixagevimab/cilgavimab for Pre-Exposure Prophylaxis
    Abraham, D.
    Lichvar, A.
    Haste, N.
    Chen, V.
    Abeles, S.
    Aslam, S.
    Binkin, N.
    Yam, N.
    Horton, L.
    Chen, B.
    Brubaker, A.
    Law, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S655 - S655
  • [39] Cardiovascular risk profile before and after tacrolimus conversion in kidney transplant recipients.
    Luan, Fu L.
    Miles, Clifford D.
    Blosser, Christopher
    Cibrik, Diane M.
    Norman, Silas
    Chopra, Pavan
    Ojo, Akinlolu A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 534 - 534
  • [40] Covid-19 Breakthrough Infections in Vaccinated Solid Organ Transplant Recipients Who Received Tixagevimab/Cilgavimab [evusheldtm] for Pre-Exposure Prophylaxis
    Alahmdi, B.
    Aberg, J.
    Patel, G.
    Adams, V.
    Jacobs, S.
    Smith, C.
    Rampertaap, K.
    Aragon, J.
    Hynes, K.
    Rana, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S671 - S671